Anti-podocalyxin antibodies and methods of using the same
US11390673B2 · kind B2 · utility
1Cited by
3References
17Claims
0Family size
Inventors
Key dates
| Filing date | Aug 12, 2019 |
| Grant date | Jul 19, 2022 |
| Priority date | — |
| Expiry date | Oct 3, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to compositions of matter useful for the treatment of cancer in mammals and to methods of using those compositions of matter for the same. Antibodies specific for podocalyxin designated Ab1 and 3G2 are disclosed, as is the use of said antibodies for the inhibition of growth of a tumor that expresses podocalyxin, and the use of said anti bodies for targeting tumour endothelial cells that express podocalyxin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.